NDAQ:ACXP) Acurx Pharmaceuticals, Inc. Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ...

Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection: Staten Island, New York Tuesday, January 7, 2025, 18:00 ...

At Dyadic, we remain committed to leveraging our innovative C1 and Dapibus protein production platforms to address some of the most pressing ...

This important study reveals a new mechanism for gene regulation in neurons by an RNA binding protein called RBM20 previously studied in the heart. The methods used are compelling, including the ...

The researcher has given an overview on the regulatory network of extracellular circRNAs in cancer and their impact on cancer drug resistance. In order to propagate malignancy, circRNAs shuttle ...

Acurx has now received positive written responses from the EMA (European Medicines Agency) under its Scientific Advice Procedure that the clinical, non-clinical and ...

Dyadic management will attend the J.P. Morgan Healthcare Conference in San Francisco, January 13–16, 2025. If you would like to schedule a meeting, please contact Dyadic at assistant@dyadic.com. About ...

A genetic test typically involves submitting a saliva sample to a laboratory. Scientists then extract DNA from the saliva and ...

A study from the University of Adelaide and The Australian National University (ANU) has outlined the first genomic evidence ...